Voluntis launches upgraded insulin dosing therapeutic

In case you missed it

• Saluda Medical wins another investment from Medtronic
• FDA wants tighter control of certain prostate ablation devices
• Ex-NuVasive CEO Lukianov gets in on Fusion Robotics
• Wall Street shrugs as Boston Scientific sets growth goals
• ConforMIS lines up $33m financing
• Medtronic covers upsized $4B tender with €5B notes offering
• Report: Smith & Nephew mulls shift to U.S. listing
• Brazil ANVISA modifies custom-made medical device regulations
• Boston Scientific opens Irish facility
• Hillrom’s Welch Allyn wins $100m Defense contract
• Transplant Biomedicals touts kidney transport device study results
• Report: Sharpless, two others in running for FDA chief | Personnel Moves, June 25, 2019
• AbbVie to buy Allergan for $6.3B
• MiRus more than doubles plant size with Georgia facility buy
• Zoll warns on AED Pro defibrillator issue
• InterVene raises $15m Series B for BlueLeaf venous valve repair device
• FDA OKs trial for Micro Medical’s below-the-knee stent